Roseburia intestinalis ‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses
Journal of Extracellular Vesicles · 2024
DOI: 10.1002/jev2.12487 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Extracellular Vesicles, 2024. Verfasst von Hwa Seung Han und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Marine Bio-Food Science, Gangneung-Wonju National University, Gangneung, Republic of Korea. Hauptthemen laut MEDLINE: Extracellular Vesicles, Gastrointestinal Microbiome, Colitis. Die Arbeit wurde bisher 72-mal zitiert (Crossref) und nennt 107 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Research Foundation of Korea, Gangneung-Wonju National University, Ministry of SMEs and Startups.
Abstract (Originalsprache)
Inflammatory bowel disease (IBD) is a chronic disorder characterized by recurrent gastrointestinal inflammation, lacking a precise aetiology and definitive cure. The gut microbiome is vital in preventing and treating IBD due to its various physiological functions. In the interplay between the gut microbiome and human health, extracellular vesicles secreted by gut bacteria (BEVs) are key mediators. Herein, we explore the role of Roseburia intestinalis ( R )‐derived EVs (R‐EVs) as potent anti‐inflammatory mediators in treating dextran sulfate sodium‐induced colitis. R was selected as an optimal BEV producer for IBD treatment through ANCOM analysis. R‐EVs with a 76 nm diameter were isolated from R using a tangential flow filtration system. Orally administered R‐EVs effectively accumulated in inflamed colonic tissues and increased the abundance of Bifidobacterium on microbial changes, inhibiting colonic inflammation and prompting intestinal recovery. Due to the presence of Ile‐Pro‐Ile in the vesicular structure, R‐EVs reduced the DPP4 activity in inflamed colonic tissue and increased the active GLP‐1, thereby downregulating the NFκB and STAT3 via the PI3K pathway. Our results shed light on the impact of BEVs on intestinal recovery and gut microbiome alteration in treating IBD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Marine Bio-Food Science, Gangneung-Wonju National University, Gangneung, Republic of Korea.
- Natural Product Informatics Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Republic of Korea.
- NVience Inc., Seoul, Republic of Korea.
- Natural Product Research Center, Korea Institute of Science and Technology (KIST), Gangneung, Republic of Korea.
ORCID-Profile: Soonjae Hwang, Seung Young Choi
Förderung
- National Research Foundation of Korea
- Gangneung-Wonju National University
- Ministry of SMEs and Startups
Zitieren
APA
Han, H. S., Hwang, S., Choi, S. Y., Hitayezu, E., Humphrey, M. A., Enkhbayar, A., Song, D. G., Kim, M., Park, J. S., Park, Y. T., Park, J. S., Cha, K. H., & Choi, K. Y. (2024). Roseburia intestinalis ‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses. Journal of Extracellular Vesicles. https://doi.org/10.1002/jev2.12487
Vancouver
Han HS, Hwang S, Choi SY, Hitayezu E, Humphrey MA, Enkhbayar A, et al. Roseburia intestinalis ‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses. Journal of Extracellular Vesicles. 2024. doi:10.1002/jev2.12487
BibTeX
@article{Han2024,
author = {Han, Hwa Seung and Hwang, Soonjae and Choi, Seung Young and Hitayezu, Emmanuel and Humphrey, Mabwi A and Enkhbayar, Altai and Song, Dae-Geun and Kim, Myungsuk and Park, Jong-Sung and Park, Young-Tae and Park, Jin-Soo and Cha, Kwang Hyun and Choi, Ki Young},
title = {Roseburia intestinalis ‐derived extracellular vesicles ameliorate colitis by modulating intestinal barrier, microbiome, and inflammatory responses},
journal = {Journal of Extracellular Vesicles},
year = {2024},
doi = {10.1002/jev2.12487}
}
EUVIMED